While mobile devices have improved efficiency and patient engagement while lowering costs, they’ve dramatically increased security risks. How can mHealth be safely implemented? View this slide show and learn:
• How mHealth increases security risks
• Where the greatest vulnerabilities lie
• How to improve mHealth security
Presentation given by Josep Maria Tormos from Guttmann Neurorehabilitation Hospital in the framework of the Emergence Forum Barcelona
Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014
iMinds insights on citizen health empowermentiMindsinsights
As more people are living longer than before and with chronic disease on the rise, disease prevention alone is no longer enough. Citizens need to take more control over their health – by giving them greater access to their personal health information and equipping them with tools and insights to better manage their lifestyles.
iMinds insights is a quarterly publication providing you with relevant tech updates based on interviews with academic and industry experts. iMinds is a digital research center and incubator based in Belgium.
Year after year, technology has played a role in changing the way that health care is delivered. Now in 2014, as technology continues to advance, consumers are demanding more convenient and cost effective care through increased use of mHealth and Telehealth. The mHealth + Telehealth World 2014 is must attend event for health care executives interested in learning how to most efficiently utilize Telehealth programs and mHealth practices to improve patient outcomes by promoting interoperability, sustainability, provider interest, and consumer engagement. Hear case studies, understand the ROI, and discuss ways to address critical issues – including licensing and security issues – of digital health practices.
http://www.worldcongress.com/events/HL14028/
The Extreme Future of Health Care 2014James Canton
Radical trends in health care and medicine will change business and society. This presentation fresh from Dr. James Canton's New Keynote Presentation and from his upcoming new book looks at the trends in biotech, synthetic biology, digital health, genomics, wellness and regenerative medicine that will shape the near future of our world and health. Find out what's next and how to prepare today. For more info see http://globalfuturist.com
While mobile devices have improved efficiency and patient engagement while lowering costs, they’ve dramatically increased security risks. How can mHealth be safely implemented? View this slide show and learn:
• How mHealth increases security risks
• Where the greatest vulnerabilities lie
• How to improve mHealth security
Presentation given by Josep Maria Tormos from Guttmann Neurorehabilitation Hospital in the framework of the Emergence Forum Barcelona
Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014
iMinds insights on citizen health empowermentiMindsinsights
As more people are living longer than before and with chronic disease on the rise, disease prevention alone is no longer enough. Citizens need to take more control over their health – by giving them greater access to their personal health information and equipping them with tools and insights to better manage their lifestyles.
iMinds insights is a quarterly publication providing you with relevant tech updates based on interviews with academic and industry experts. iMinds is a digital research center and incubator based in Belgium.
Year after year, technology has played a role in changing the way that health care is delivered. Now in 2014, as technology continues to advance, consumers are demanding more convenient and cost effective care through increased use of mHealth and Telehealth. The mHealth + Telehealth World 2014 is must attend event for health care executives interested in learning how to most efficiently utilize Telehealth programs and mHealth practices to improve patient outcomes by promoting interoperability, sustainability, provider interest, and consumer engagement. Hear case studies, understand the ROI, and discuss ways to address critical issues – including licensing and security issues – of digital health practices.
http://www.worldcongress.com/events/HL14028/
The Extreme Future of Health Care 2014James Canton
Radical trends in health care and medicine will change business and society. This presentation fresh from Dr. James Canton's New Keynote Presentation and from his upcoming new book looks at the trends in biotech, synthetic biology, digital health, genomics, wellness and regenerative medicine that will shape the near future of our world and health. Find out what's next and how to prepare today. For more info see http://globalfuturist.com
Ethical Considerations and Relation Centered Design for mHealth Applications Kate Michi Ettinger
Ethical Considerations and Relation Centered Design for mHealth Applications presented in the Medical Devices Track: Strategies for Successful Implementation of mHealth in Low Resource Settings chaired by Walter Karlen, PhD, Grand Challenges Canada grantee and post-doc at University of British Columbia and Stellenbosch University.
Presented June 6, 2014, at UNESCO Technology for Development 2014, theme: What is Essential?, hosted by EPFL and CODEV in Lausanne, Switzerland. For more information: http://wiki.epfl.ch/opentech4dev
Please Message To Request Copy of this Presentation for Download
Wearable Technology Futures 2020: A New Path for Public Health?Ogilvy Health
This report, Wearable Technology Futures 2020: A New Path for Public Health?, lends insight into some difficult but important questions currently challenging the health technology industry. For example, how can wearable technology better appeal to those who could most benefit from it—like the inactive or those fighting obesity—in addition to the health enthusiasts and technophiles currently embracing these wearable gadgets? Ogilvy health specialists brought their knowledge and expertise to bear on this question, as well as many others whose answers could help shape the future development of the technology.
Wearable Technology Futures 2020: A New Path for Public Health? is a three-part report: Part 1 analyses the approach developers are currently using and how this aligns with published thinking and evidence on behavior change techniques; Part 2 fuels the debate by suggesting, through six different scenarios, that the true potential of wearable technology can only be realized when we approach its application beyond the device and truly align around public health directives; and Part 3 takes an in-depth look at four popular devices and their associated apps as experienced by Ogilvy’s own user panel, clocking up a total of 23,040 hours.
Authors: David Davenport-Firth, Lexi Fletcher, Matt Balogh, Ritesh Patel, Simon Stebbing
I manage my health with digital tools and I’m not alone. An estimated and growing 69% of consumers and patients are also engaged in monitoring their own healthcare . The interest in personal wellness combined with the proliferation of healthcare ‘wearables’ available to consumer puts us on the cusp of an extraordinary shift in healthcare: Technology enabled patients are empowered to change their lifestyle to prevent or stop chronic disease, and become healthier than ever before. The implications of this on every aspect of the healthcare industry –from delivery and population health to access and cost will be astounding.
But wearable technology is still in its infancy, quite complex and limited in what it can do. The next generation will be intelligent and voice-enabled and go beyond tracking to interacting with and assisting consumers with their healthcare choices, and changing behaviors for the better. Imagine a wearable that could warn you of risks developing, nudge you towards better choices for that day based on your health profile, and keep you engaged in a treatment regime.
Today, digitalization is a catalyst for economic growth. Digitalization opens huge opportunities
for service providers to create novel solutions for consumers. For example, consumers are willing to spend
more money and time to take care of themselves and this provides new business for wellness service providers.
The aim of this paper is to provide new knowledge on how user involvement and co-design can boost
development of digital wellness services, and what are their potential benefits for companies. The paper
introduces three case studies in which novel mobile wellness services were developed in collaboration with
users in Owela platform in different phases of the development process.
Walter Greenleaf - The Impact of XR Technologies on Medical Research and Heal...Stanford University
This presentation provides an overview of how the coming wave of Virtual Reality and Augmented Reality (XR) technology will impact medicine, clinical care, and personal health and wellness.
Although entertainment, social connection, and gaming is driving drive the initial adoption of VR and AR technology, the deepest and most significant impact of the next generation of VR/AR technology will be to enhance clinical care and to improve personal health and wellness. VR and AR technology will also help facilitate the shift of medicine to direct personal care.
We know from decades of clinical research that VR/AR technology can provide breakthrough solutions that address the most difficult problems in healthcare - ranging from mood disorders such as Anxiety and Depression to PTSD, Addictions, Autism, Cognitive Aging, Stroke Recovery, and Physical Rehabilitation, to name just a few.
VR technology can also improve clinical measurements and assessments by making them more objective and functional, and improve medical training such as surgical skill training and procedure planning by applying simulation-based learning principals. Personal health and wellness will be improved by using VR to promote healthy lifestyles and to reduce stress and anxiety. As the cost of healthcare rises, VR technology can serve as an effective telemedicine platform to reduce costs of care delivery, and improve clinical efficiency.
Cancer is a dangerous ailment that influences any part of the body and could produce malignant tumors. One feature of cancer is that abnormal cells create quickly and expand beyond their regular bounds. This could attack various parts of the human body and spread to other organs, which is the primary cause of cancer death. Cancer is becoming a more serious worldwide health concern. In the face of these threats, advanced technologies such as Artificial Intelligence (AI), cognitive systems, and the Internet of Things (IoT) may be insufficient to prevent, predict, diagnose, and treat cancer. Digital Twins (DT) with a combination of IoT, AI, cloud computing, and communications technologies such as 5G and 6G have the potential to significant reduce serious cancer threats. Observing data from DT populations may aid in the improvement of some cancer screening, prediction, prevention, detection, treatment, and research investment strategies. Applications of DT medicine specifically cancer, have been studied and analyzed in this paper using both conceptual and statistical analyses. This paper also shows a tree of some ailments where DT is applicable in their study. To the best of our knowledge, there is no literature research on various illnesses and DT specifically cancer disorders. To show the potential of DT, development hurdles of utilizing DT in cancer diseases are discussed, and then, several open research directions will be explained.
Algorithms and bias: What lenders need to knowWhite & Case
The algorithms that power fintech may discriminate in ways that can be difficult to anticipate—and financial institutions can be held accountable even when alleged discrimination is clearly unintentional.
Virtual Reality and Healthcare - The Past, the Present, and the FutureStanford University
A presentation about Virtual Reality, Augmented Reality and Healthcare -
The history of the field, the current status, and a perspective about future directions.
University of California Center for Health Leadership Mobile workshopmikekirkwood
Workshop building baseline mobile health landscape, scenario description, and development workshop given by Mike Kirkwood in Oakland California on 11/17/2010.
Are we really mHealth ready yet? How are we going to use it for healthcare delivery? Who is the tar-get audience and who is going to consume these services? Do we have plans available to educate the community and make them aware of the benefits of mHealth? There are hundreds of questions lying underneath which need to be answered before we claim to make a difference using mHealth. This paper briefly reviews the arrival & advantage of ICT in healthcare followed by mobile revolution and introduction of mHealth and its potential contribution in Healthcare delivery and our readiness to embrace it.
Please cite as: Kamel Boulos MN. Creating self-aware and smart healthy cities. Invited plenary keynote address followed by sub-plenary round table at WHO 2014 International Healthy Cities Conference, Athens, Greece, 25 October 2014. http://www.healthycities2014.org/ehome/89657/192014/?&
PPT updated in May 2015.
Oct 2017: See also https://www.slideshare.net/sl.medic/how-the-internet-of-things-and-people-can-help-improve-our-health-wellbeing-and-quality-of-life
Eliminating Machine Bias - Mary Ann Brennan - ML4ALL 2018MaryAnnBrennan3
Slides from Mary Ann Brennan's ML4ALL Machine Learning conference talk on Machine Bias. Machine Learning algorithms often exhibit systematic, unfair bias against certain groups of people, all while the supposed impartiality of machines dissolves accountability. I touch on definitions, criminal justice, and solutions and finish with a success story from NLP and a slide listing resources. Video here: https://www.youtube.com/watch?v=VksAAI60GEc
With this presentation, the objective was to explain to an IT industry audience what eHealth, mHealth and telehealth is, not from an IT but an healthcare transformation perspective.
Ethical Considerations and Relation Centered Design for mHealth Applications Kate Michi Ettinger
Ethical Considerations and Relation Centered Design for mHealth Applications presented in the Medical Devices Track: Strategies for Successful Implementation of mHealth in Low Resource Settings chaired by Walter Karlen, PhD, Grand Challenges Canada grantee and post-doc at University of British Columbia and Stellenbosch University.
Presented June 6, 2014, at UNESCO Technology for Development 2014, theme: What is Essential?, hosted by EPFL and CODEV in Lausanne, Switzerland. For more information: http://wiki.epfl.ch/opentech4dev
Please Message To Request Copy of this Presentation for Download
Wearable Technology Futures 2020: A New Path for Public Health?Ogilvy Health
This report, Wearable Technology Futures 2020: A New Path for Public Health?, lends insight into some difficult but important questions currently challenging the health technology industry. For example, how can wearable technology better appeal to those who could most benefit from it—like the inactive or those fighting obesity—in addition to the health enthusiasts and technophiles currently embracing these wearable gadgets? Ogilvy health specialists brought their knowledge and expertise to bear on this question, as well as many others whose answers could help shape the future development of the technology.
Wearable Technology Futures 2020: A New Path for Public Health? is a three-part report: Part 1 analyses the approach developers are currently using and how this aligns with published thinking and evidence on behavior change techniques; Part 2 fuels the debate by suggesting, through six different scenarios, that the true potential of wearable technology can only be realized when we approach its application beyond the device and truly align around public health directives; and Part 3 takes an in-depth look at four popular devices and their associated apps as experienced by Ogilvy’s own user panel, clocking up a total of 23,040 hours.
Authors: David Davenport-Firth, Lexi Fletcher, Matt Balogh, Ritesh Patel, Simon Stebbing
I manage my health with digital tools and I’m not alone. An estimated and growing 69% of consumers and patients are also engaged in monitoring their own healthcare . The interest in personal wellness combined with the proliferation of healthcare ‘wearables’ available to consumer puts us on the cusp of an extraordinary shift in healthcare: Technology enabled patients are empowered to change their lifestyle to prevent or stop chronic disease, and become healthier than ever before. The implications of this on every aspect of the healthcare industry –from delivery and population health to access and cost will be astounding.
But wearable technology is still in its infancy, quite complex and limited in what it can do. The next generation will be intelligent and voice-enabled and go beyond tracking to interacting with and assisting consumers with their healthcare choices, and changing behaviors for the better. Imagine a wearable that could warn you of risks developing, nudge you towards better choices for that day based on your health profile, and keep you engaged in a treatment regime.
Today, digitalization is a catalyst for economic growth. Digitalization opens huge opportunities
for service providers to create novel solutions for consumers. For example, consumers are willing to spend
more money and time to take care of themselves and this provides new business for wellness service providers.
The aim of this paper is to provide new knowledge on how user involvement and co-design can boost
development of digital wellness services, and what are their potential benefits for companies. The paper
introduces three case studies in which novel mobile wellness services were developed in collaboration with
users in Owela platform in different phases of the development process.
Walter Greenleaf - The Impact of XR Technologies on Medical Research and Heal...Stanford University
This presentation provides an overview of how the coming wave of Virtual Reality and Augmented Reality (XR) technology will impact medicine, clinical care, and personal health and wellness.
Although entertainment, social connection, and gaming is driving drive the initial adoption of VR and AR technology, the deepest and most significant impact of the next generation of VR/AR technology will be to enhance clinical care and to improve personal health and wellness. VR and AR technology will also help facilitate the shift of medicine to direct personal care.
We know from decades of clinical research that VR/AR technology can provide breakthrough solutions that address the most difficult problems in healthcare - ranging from mood disorders such as Anxiety and Depression to PTSD, Addictions, Autism, Cognitive Aging, Stroke Recovery, and Physical Rehabilitation, to name just a few.
VR technology can also improve clinical measurements and assessments by making them more objective and functional, and improve medical training such as surgical skill training and procedure planning by applying simulation-based learning principals. Personal health and wellness will be improved by using VR to promote healthy lifestyles and to reduce stress and anxiety. As the cost of healthcare rises, VR technology can serve as an effective telemedicine platform to reduce costs of care delivery, and improve clinical efficiency.
Cancer is a dangerous ailment that influences any part of the body and could produce malignant tumors. One feature of cancer is that abnormal cells create quickly and expand beyond their regular bounds. This could attack various parts of the human body and spread to other organs, which is the primary cause of cancer death. Cancer is becoming a more serious worldwide health concern. In the face of these threats, advanced technologies such as Artificial Intelligence (AI), cognitive systems, and the Internet of Things (IoT) may be insufficient to prevent, predict, diagnose, and treat cancer. Digital Twins (DT) with a combination of IoT, AI, cloud computing, and communications technologies such as 5G and 6G have the potential to significant reduce serious cancer threats. Observing data from DT populations may aid in the improvement of some cancer screening, prediction, prevention, detection, treatment, and research investment strategies. Applications of DT medicine specifically cancer, have been studied and analyzed in this paper using both conceptual and statistical analyses. This paper also shows a tree of some ailments where DT is applicable in their study. To the best of our knowledge, there is no literature research on various illnesses and DT specifically cancer disorders. To show the potential of DT, development hurdles of utilizing DT in cancer diseases are discussed, and then, several open research directions will be explained.
Algorithms and bias: What lenders need to knowWhite & Case
The algorithms that power fintech may discriminate in ways that can be difficult to anticipate—and financial institutions can be held accountable even when alleged discrimination is clearly unintentional.
Virtual Reality and Healthcare - The Past, the Present, and the FutureStanford University
A presentation about Virtual Reality, Augmented Reality and Healthcare -
The history of the field, the current status, and a perspective about future directions.
University of California Center for Health Leadership Mobile workshopmikekirkwood
Workshop building baseline mobile health landscape, scenario description, and development workshop given by Mike Kirkwood in Oakland California on 11/17/2010.
Are we really mHealth ready yet? How are we going to use it for healthcare delivery? Who is the tar-get audience and who is going to consume these services? Do we have plans available to educate the community and make them aware of the benefits of mHealth? There are hundreds of questions lying underneath which need to be answered before we claim to make a difference using mHealth. This paper briefly reviews the arrival & advantage of ICT in healthcare followed by mobile revolution and introduction of mHealth and its potential contribution in Healthcare delivery and our readiness to embrace it.
Please cite as: Kamel Boulos MN. Creating self-aware and smart healthy cities. Invited plenary keynote address followed by sub-plenary round table at WHO 2014 International Healthy Cities Conference, Athens, Greece, 25 October 2014. http://www.healthycities2014.org/ehome/89657/192014/?&
PPT updated in May 2015.
Oct 2017: See also https://www.slideshare.net/sl.medic/how-the-internet-of-things-and-people-can-help-improve-our-health-wellbeing-and-quality-of-life
Eliminating Machine Bias - Mary Ann Brennan - ML4ALL 2018MaryAnnBrennan3
Slides from Mary Ann Brennan's ML4ALL Machine Learning conference talk on Machine Bias. Machine Learning algorithms often exhibit systematic, unfair bias against certain groups of people, all while the supposed impartiality of machines dissolves accountability. I touch on definitions, criminal justice, and solutions and finish with a success story from NLP and a slide listing resources. Video here: https://www.youtube.com/watch?v=VksAAI60GEc
With this presentation, the objective was to explain to an IT industry audience what eHealth, mHealth and telehealth is, not from an IT but an healthcare transformation perspective.
Telehealthcare for older people with comorbidity: lessons from eCAALYXand pr...Maged N. Kamel Boulos
Invited presentation by MN Kamel Boulos at http://www.aal-europe.eu/innovate-uk/ (12 March 2013) - (C) The eCAALYX Project Consortium - http://ecaalyx.org/
mHealth Israel_Ralf Jahns_Research2Guidance_The EU Countries’ mHealth App Mar...Levi Shapiro
The EU Countries’ mHealth App Market Ranking 2015, by Ralf Gordon Jahns, CEO of Research2Guidance. Presentation made at the mHealth Israel Investors Summit, June, 2015
Federal and State Telehealth Policy and Reimbursement: What You Should KnowLaura Kimball
Hosted by GlobalMed with Guest Presenter Mario Gutierrez from the Center for Connected Health Policy (CCHP). Gutierrez, Executive Director of the CCHP, provides an overview of telehealth policy focusing on:
- Medicare & Telehealth
- Medicaid & Telehealth in the 50 states
- Legal Considerations for providers starting telehealth
programs
- Pending Telehealth Legislation & U.S. Telehealth Policy Trends
This is the first report on Telehealth in India, and was authored in 2011 by Rajendra Pratap Gupta for Telemedicine Society of India , when he chaired the Organising Committee of the International Telemedicine Congress 2011 at Mumbai
This report gives a detailed overview of where India stands and what is the scope in future
Upcoming Webinar: Building Value from Mobile Health (mHealth)Nous Infosystems
Join us to understand how mHealth can impact your organization via this exclusive webinar hosted by Nous Infosystems in association with Kony, Inc. on June 24.
Register today - http://goo.gl/1efG8B
Beyond telehealth: Maximizing value based care - Robin Wiener, Get Real Healt...VSee
What is a platform-based patient portal? Why is it important for maximizing value based care? - from the Telehealth Failures & Secrets To Success Conference:
vsee.com/telehealth-failures-conference
How value based care is changing telehealth payment modelsVSee
For more information of the presentation such as recording and transcript, please visit:
https://goo.gl/7AdJy2
For other webinars:
https://vsee.com/webinars/
Or join our Linkedin Group: https://www.linkedin.com/groups/Telehealth-Failures-Secrets-Success-13500037/about
Or Join our Facebook Group:
https://www.facebook.com/groups/tfssgroup/?ref=group_cover
CareClix is the leading telemedicine providers Worldwide. Now the Patients can see their doctors from home via the electronic devices and physicians at CareClix examine the multiple patients at the same time with CareClix Medical Examination room.
Usability Lessons From National Healthcare AppsCyber-Duck
From our webinar, The Good, The Bad & The Ugly - Usability Lessons From National Healthcare Apps.
Discover our presentation for World Usability Day, as we shine a light on the impact of digitalisation on public health services, specifically through the lens of delivering great user experiences and better patient care with healthcare apps.
Information+Integration ? Innovation an HL7/EFMI/HIMSS @eHealthweek2015 in Rigachronaki
Join us to explore “Interoperability in action: information + integration = innovation?” and engage in lively debate on how rethinking interoperability standards and continuing education can bridge divides, change cultures, and open markets!
Perspectives from health management, industry, government, health education, and standardization exemplify challenges and opportunities for liberation of data that can drive desired social and technological innovation.
This is a call for action to explore how the partnership of HL7, EFMI and HIMSS can catalyze the equation “information + integration = innovation” to bridge divides, change culture and open markets.
Peter J. Murray RN, PhD, MSc, CertEd, FBCS CITP
CEO, International Medical Informatics Association (IMIA) and Director, CHIRAD Africa
(3/11/10, Illott, 4.00)
Mobile health is an ever expanding field, and shows great promise for delivering care to remote patients. In this presentation at the ATA 2012 conference, Dr. Robert Ciulla demonstrates the potential for mHealth to improve care availability and how T2 is supporting that goal.
E health in Nigeria Current Realities and Future Perspectives. A User Centric...Ibukun Fowe
In this era of the digital revolution, innovative computer software programs and Information and communications technologies (ICTs) are disrupting different industries of most economies and the healthcare sector is one of the nascent and emerging opportunities for technology disruption and innovation. This is an “inevitable” welcome development as Global health innovation is at the forefront of embracing the use of technology solutions in various parts of the world to improve access to health services and medicines, and Nigeria is not to be an exception. This symposium is focused on asking the fundamental questions; how much impact are e-health applications making in the Nigerian health sector and how do we improve the level of impact and
effectiveness of these applications via a user-centric approach?
Taking these proactive steps serve to ensure that we focus on the real needs of the Nigerian people and put in place quality and safety measures that will give users the confidence needed to use e-health applications and solutions adequately and appropriately. This symposium invites key-stakeholders in the e-health
ecosystem to share their views on the pains and gains of e-health as of today and how to shape the future of e-health in Nigeria (and similar countries). Some of the presentations and panelist sessions will include real field experience and user-centered qualitative research that will elicit the current level of impact and the real needs of e-health users in the southwest region of Nigeria.
Professor George Crooks - ECO 19: Care closer to homeInnovation Agency
Presentation by Professor George Crooks, Chief Executive Officer, The Digital Health and Care Innovation Centre at ECO 19: Care closer to home on Tuesday 9 July at Deepdale Stadium.
Unleashing the Potential of Remote Monitoring: Data-Driven Insights for Teleh...Rajashree Bhabad
Discover the future of healthcare with our whitepaper, "Unleashing the Potential of Remote Monitoring: Data-Driven Insights for Telehealth." As telehealth gains prominence, remote monitoring emerges as a game-changer, powered by wearable devices, IoT, and connected medical technologies. This abstract explores how data-driven insights are revolutionizing patient care, empowering providers, and shaping public health strategies. Delve into the ethical considerations, clinical applications, and transformative impact of remote monitoring. Uncover challenges, opportunities, and the path to a patient-centric future through technological collaboration. Join us in embracing the convergence of data and healthcare to create a new era of accessible, cost-effective, and personalized healthcare solutions.
EHR with Health Applications b.sc ii Sem.pptxanjalatchi
EHRs are a vital part of health IT and can: Contain a patient's medical history, diagnoses, medications, treatment plans, immunization dates, allergies, radiology images, and laboratory and test results. Allow access to evidence-based tools that providers can use to make decisions about a patient's care.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
mHealth, telehealth and the digital society: Where does the ‘value’ lie?
1. mHealth, telehealth and the digital society:
Where does the ‘value’ lie?
Claudia Pagliari PhD FRCPE
Senior Lecturer in Primary Care
Convener eHealth Interdisciplinary Research Network
The University of Edinburgh Medical School
HINZ Conference, Rotorua
Nov 8th, 2012
2. Presentation will examine
• Environment & ‘ecosystems’
• Policy context & digital society
• Vision for transformation & benefits
• Challenges & possible disbenefits
• Complexity & value chains
• Some issues for the future
3. Overlapping concepts
Typically more
policy driven,
eHealth - Use of networked ICT to support the organisation &
system centred &
delivery of health care
controlled
Telehealth – Subfield concerned with supporting remote care
provision or enabling patient self-care via condition monitoring
Typically more
mHealth - Use of wireless devices, networks & ‘apps’
consumer driven, to support the management of health and wellness.
user-centred, less Increasingly underpins telehealth interventions
controlled
[Multiple definitions and terminologies exist e.g. Digital Health, Telemedicine etc. Terms are poorly defined and subfields overlap considerably]
4. Mobile and internet use are growing & changing
Source: Predicted rise of 4G in developed Asia Pacific regions
Gartner
Source: www.analysysmason.com
10. Personal ecosystem
• Increasing device interoperability & cloud computing ->
– health as part of digital lifestyle (social networking, finance,
entertainment, education, home eco-logistics etc.)
– always on, ever present, IoT, unrestricted data volumes
– Flexible & personalised
11. Personalised eHealth
– Personal Health Records
– Personal Health Self-Management Systems
– Tailored health messaging
– Choice-based consulting
“What we are starting to see is a patient-
– Tailored telehealthcare led healthcare revolution”
Orion COE quoted in Pulse IT Oct 2012
12. Where does eHealth sit in the
policy landscape?
…a quick view from Europe
13. Seven Pillars of the
‘Digital Agenda for Europe’
• Pillar 1: A vibrant digital single market
• Pillar 2: Interoperability and standards
• Pillar 3: Trust and security
• Pillar 4: Fast and ultra-fast Internet access
• Pillar 5: Research and innovation
• Pillar 6: Enhancing digital literacy, skills and inclusion *
• Pillar 7: ICT-enabled benefits for EU society
• eHealth
Digital Society • eGovernment
Digital Economy
14. “The Digital Agenda will support the
development of eHealth though actions to
equip Europeans with secure online access
to their medical health data by 2015 and to
achieve by 2020 widespread deployment of
telemedicine services”
European Commission (2010) Digital Agenda for Europe. Action 75.
16. Stating the obvious
• Mobile brings
– Convenience
– Portability
– Accessibility
– Flexibility
• Already part of our lifestyle
• iPads & apps are sneaking into the workplace
• Mobile telehealthcare taking place informally
17. ‘Transformation’
• Key theme in the prevailing narrative
...of services, business processes, relationships
• e.g. “mHealth is about distributing care beyond clinics and
hospitals and enabling new, information-rich, relationships
that drive better healthcare decisions by patients and
providers” (Intel speaker at mHealth 2011)
• ‘Horizontal alignment’ of patients and clinicians?
e.g. Marceglia et al (2012) How might the iPad change healthcare? JRSM 105
18. The BIG promises
• m- & tele- health will
– A) save money
– B) improve patient outcomes
e.g "mHealth …solutions deliver health. The ubiquity of
mobile devices … presents the opportunity to improve
health outcomes"
www.mhealthalliance.org/about/frequently-asked-questions
20. Dangers in ‘overselling’
"We've trialled it, it's been a huge success, and
now we're on a drive to roll this out
nationwide," ... "The aim - to improve three
million lives over the next five years”
David Cameron. 5th December 2011
Headline findings announced in Parliament long before trial
results were published. Researchers’ conclusions more cautious …
“If used correctly…”
21. Market forces
• Hype often disguises a mismatch between ‘inflated
expectations’ and reality
• Market forces are shaping the appiverse
– Natural selection, sometimes unpredictable
• Many consumer health apps functionally worthless
– “For entertainment purposes only”
• When does it matter, when does it not?
– Context, purpose, risk, expectation
25. State of the evidence?
• Systematic reviews reveal mixed picture
• Lack of rigorous, well-theorised studies
• Not clear what is being evaluated
• Most evaluations take health service perspective
• Poor integration of social & economic indicators
Mistry (2012) Systematic review of studies of the cost-effectiveness of telemedicine and telecare. Changes in the economic evidence
over twenty years. Jn Telemed & Telecare
Black et al. (2011) The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview. PLoS Med 8
McLean (2011) Two systematic reviews on telehealth for asthma (Cochrane database) and COPD (Can Ass Med Journal)
Balas et al (2009) Healthcare via cell phones: a systematic review. Telemed J E Health
Forthcoming in PloS Med: Systematic reviews by Free et al. on effectiveness of mHealth for improving health and health services.
Older but relevant: Jennet et al (2003) Socioeconomic impact of telehealth: Systematic review. Jn Telemed &Telecare
Conclusions supported by recent expert consensus (e.g. Whittaker 2012, JMIR)
26. Testing the Value Proposition
Proposition: m-Health will save money for HS
e.g. by supporting healthy living with LTC, keeping
the elderly out of hospital
• But what will it cost to implement?
• Is it the technology that makes the difference?
Proposition: mHealth will make money
by offering sellable benefits
• what type (e.g. choice, convenience, access, life years,
monetary savings), and to whom?
Proposition: The market is willing to pay
• Which markets (provider, insurer, government, citizen,
patient, carer) and why?
27. More than the gadgets…
• Economists and sociologists are revisiting concepts of ‘value’
in the digital age and recognising that it comes from what we
get out of interacting with technology, not from the
technology itself.
• We ‘co-create’ value.
Value comes from the whole system, not
the components, from what it can ‘do’
rather than what it ‘is’, and from what
the thing it can do offers to the people
who use it, at the time and place they
use it.
Slide by Irene Ng
28. A few challenges…
• Devices, back end services & training cost money
– Who will pay?
• For what types of devices or applications?
– What is the critical RoI to leverage state investment?
– When is it necessary and when is it just nice to have?
• Costs can increase where systems haven’t evolved to
accommodate innovations
– Technology needs to be tamed* in order to integrate
– Where does this leave the business case?
– How much faith do we need?
– Do we need to question our expectations/theory?
* Pols & Willems (2011). Taming & unleashing telecare. Sociology of Health & Illness; Ure et al (2011) Piloting tele-monitoring in COPD:
exploration of issues in design and implementation. Primary Care Respiratory Journal
29. Complexity, impact & value
• What you think you’re buying (off-the-shelf solution)
may not be the same as what you’re actually getting
(opportunity to reconfigure your service)
• Need to ask:
– What process changes are needed to implement this
service?
– At the end of the day, what is ‘the intervention’?
• Likely costs vs. savings? Do the sums add up?
– Will they add up once this has been embedded?
• Sponsored evaluations typically <6 mth
30. Tales of the Unexpected
Some insights from our research
31. Supported COPD monitoring
Phase Driver Intervention? Method Sponsor
Procure- Sale of concept by major Tech: VC, monitoring, Researchers flag
ment vendor. Goal to reduce decision support, importance of
admissions through education formative evaluation
home telehealth Vision: Nexus of GP &
patient
Design & Questions over Planning process shifts Qualitative Technology
set-up readiness, fit, emphasis to nurse-led observation & supplier
configuration service with call-centre interviews
Trial in Need for evidence of Specialist nurse-led RCT with Gov.
practice value & safety service with or without embedded qualitative research
‘telehealth’. No call Study programme
centre or VC
• Quantitative: No difference in admissions or mortality. Clinical indicators improve in both
trial arms. Prescribing costs increase.
• Qualitative. Vision very different from what emerged. Patient satisfaction high (perceived
safety, access, legitimisation). Uncertainty over ‘normal’ readings. Key change agents:
high nurse-patient engagement; service redesign & optimisation
Pinnock et al (2009) PCRJ; Ure et al (2011) PCRJ
32. mHealth for asthma
Phase Driver Intervention? Method Sponsor
Formative Producer seeking Mobile self- Qualitative study Industry
pilot insights to inform monitoring via
developments peripherals with
automated feedback
Trial in Need for evidence Updated version of RCT Asthma
practice of outcomes & product charity
practicality
Results from trial:
– No difference in clinical outcomes
– Both groups improved, suggesting telehealth not the critical factor (care ‘optimised’ in both
groups)
Ryan et al. (2012) Clinical and cost-effectiveness of mobile phone supported self-
– Phone more expensive monitoring of asthma: multi-centre randomised controlled trial BMJ 344
Insights from pilot: Most likely to be used by people adapting to asthma
– Issue for market segmentation & value
Pinnock et al. (2009) Understanding the potential role of mobile phone-based
monitoring on asthma self-management: qualitative study. Clin Exp All 37
33. Supported home BP monitoring
Phase Driver Intervention? Method Sponsor
Post Academic & clinician Mobile reminders to check BP RCT Government
market interest using peripherals linked to mobile health research
• Common consumer phone. Automated feedback & agency +
device purchase advice with weekly clinician review supplier (kit)
• Equivocal evidence and immediate response if outwith
safe thresholds
Results from trial:
– Significant improvement in BP compared to usual care. No difference in other outcomes
– Increased prescription of drugs in the actively monitored group.
– Clinician and nurse time (and cost) also increased
Interpretation:
– Telehealth made readings impossible for primary care staff to ignore, leading to increased
use of antihypertensives, but did not influence patient lifestyle
– Technology as catalyst, not cause
Padfield et al (2012) ) Early Results from the Health Impact of Telemetry-Enabled
Self-monitoring (HITS) Trial. Conference paper. British Hypertension Society
34. mHealth for paediatric diabetes
Phase Driver Intervention? Method Sponsor
Development Poor medication Scheduled SMS messages RCT with Diabetes charity
& evaluation compliance in tailored to personalised embedded and mobile
adolescents. clinical goals and qualitative network
Reported benefits of motivational drivers (‘push study provider
costly high effort goal- support’)
directed interventions
Quantitative :
– No difference in Hba1c compared to usual care
– Increase in clinic visits
– Increase in self-efficacy and self-reported adherence
Qualitative:
– Patients actively sought interaction with a system designed mainly to ‘push’ messages
– Some believed the automated messages were coming from a human
Soft benefits (e.g. self-efficacy) may add value downstream e.g. aiding transition to intensive insulin therapy
Franklin et al (2006 ) Randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabetic Medicine
Franklin et al (2008) Patients’ Engagement With “Sweet Talk” – A Text Messaging Support System for Young People With Diabetes. JMIR 10 (2)
36. Information security & privacy
• Data custodianship & liabilities unclear
• Risks due to
– Technical/system issues
– Human error
– Malign intent
Greater knowledge about data harvesting
& security will deter some users
Will it also spawn techno sub-cultures?
37. Safety
Users can co-create risk as well as value…
– Patients
• Dangers of false expertise
• Unwarranted trust in junk apps
• Unjustified trust in systems or their overseers
• Dependency vs. self-reliance
– Professionals
• Under-the counter clinical transactions
• Context-inappropriate tools
• Failure to integrate hand-held & organisational data
• Failure to define lines of responsibility
38. Societal risks: Equity
– Those with greatest need may be in worst position to
benefit from eHealth
– Avoiding ‘double dip’ requires tailored solutions that
capitalise on familiar & available technologies
• e.g. ‘edutainment’ & social media for the young, DTV &
videophones for the elderly
– Important not to further isolate the disenfranchised
through digital ‘help’
– Hype around mHealth for developing nations is obscuring
still vast disparities in health & access to medical care
39. Psychosocial risks
UK Financial Times, August 4, 2011
Teenagers ‘addicted’ to using smartphones
“Just under half of British children aged 12 to 15 own a
smartphone, with many claiming to be “addicted” to the
devices, which they use while eating, at the cinema and in
bed” (Source: Ofcom)
Journal of Public Health, May 2011
“Problematic mobile phone use in adolescence should
become a public health issue” (Martinotti et al.)
http://www.springerlink.com/content/u05163w878367037/
40. Physical risks: Can mobiles cause cancer?
May 2011: WHO finally concedes it may be ‘possible’
July 2011: Danish observational study suggests not
April 2012: Dedicated conference takes place in London
June-Oct 2012: Major western health agencies release new, reassuring, analyses
Oct 2012: Nature blog reports a successful Italian lawsuit by a cancer patient
2013-50??
What level of risk would make us
give up our mobiles?
What’s the trade-off for mHealth?
e.g. http://www.youtube.com/watch?v=K4uz2TUcwnI
41. Looking the future…
• Smart phones, tablets, cloud and IoT become the norm
• With pervasive systems the term ‘mobile’ becomes redundant
• The eHealth sector explodes & then rationalises as evidence
accumulates, value chains are clarified & market segmentation
is better understood
• Return on government investments in HIT is demonstrated
• As society ‘digitises’ eHealth integrates with consumer-centred
platforms and already-owned devices
• Tensions between the need to innovate for growth and the
need to control quality, spending & governance continue…
42. Key issues for ‘value’
• Without better evidence current levels of spending on
telehealth & mHealth cannot easily be justified
• Complexity presents challenges for demonstrating RoI
• Value is co-created by systems & users
– Lack of clinical or economic impact does not mean lack of value
• But ‘soft’ impacts can be hard to monetise
– Evidence of clinical impacts may confuse human & technological causes
• In this fast-moving environment creative paradigms are needed
to evaluate technology programmes while they happen
It’s not a no-brainer